Copenhagen, Denmark

Lars Kristian Albert Blæhr

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Leo-Pharma A/s. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars Kristian Albert Blæhr. Retrieved from https://idiyas.com/inventor/lars-kristian-albert-blæhr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars Kristian Albert Blæhr: Innovator in Pharmaceutical Compounds

Introduction

Lars Kristian Albert Blæhr is a notable inventor based in København Ø, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate calcium-sensing receptors.

Latest Patents

Lars holds a patent for "Calcium sensing receptor modulating compounds and pharmaceutical use thereof." This patent involves calcium-sensing receptor (CaSR) modulating substituted cyclopentylene compounds represented in formula I, where X is CH or N. These compounds and their pharmaceutical compositions are useful for treating various diseases.

Career Highlights

Lars is currently employed at Leo Pharma A/S, a company renowned for its focus on dermatology and critical care. His work at Leo Pharma A/S has allowed him to explore innovative solutions in the pharmaceutical industry.

Collaborations

Lars has collaborated with notable colleagues, including Bjarne Nørremark and Anne Eeg Knapp, contributing to advancements in their shared field of expertise.

Conclusion

Lars Kristian Albert Blæhr's work exemplifies the impact of innovative thinking in pharmaceuticals. His contributions continue to influence the treatment of diseases through novel compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…